Camins, Antoni

Metal-Based Nanoparticles as Antimicrobial Agents: An Overview

Sánchez-López, E., Gomes, D., Esteruelas, G., Bonilla, L., Lopez-Machado, A. L., Galindo, R., Cano, A., Espina, M., Ettcheto, M., Camins, A., et al. (2020) · Nanomaterials

Nanoparticles: synthesis and applicationsAntimicrobial agents and applications

Cited by 1,474

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., et al. (2019) · Journal of Controlled Release

Alzheimer's disease research and treatmentsNanoparticle-Based Drug Delivery

Cited by 337

Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment

Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 270

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

Folch, J., Busquets, O., Ettcheto, M., Sánchez-López, E., Castro-Torres, R. D., Verdaguer, E., Garcia, M. L., Olloquequi, J., Casadesús, G., Beas-Zarate, C., et al. (2018) · Journal of Alzheimer s Disease

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 245

High-fat Diet-Induced Deregulation of Hippocampal Insulin Signaling and Mitochondrial Homeostasis Deficiences Contribute to Alzheimer Disease Pathology in Rodents

Petrov, D., Pedrós, I., Artiach, G., Sureda, F. X., Barroso, E., Pallàs, M., Casadesús, G., Beas-Zarate, C., Carro, E., Ferrer, I., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 163

Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus

Rimbau, V., Camins, A., Romay, C., González, R., & Pallàs, M. (1999) · Neuroscience Letters

Neuroprotection in Cerebral IschemiaAlzheimer's disease research and treatments

Cited by 130

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

Viayna, E., Coquelle, N., Cieslikiewicz-Bouet, M., Cisternas, P., Oliva, C. A., Sánchez-López, E., Ettcheto, M., Bartolini, M., De Simone, A., Ricchini, M., et al. (2021) · Journal of Medicinal Chemistry

Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments

Cited by 106

Effects of Nutrition on Cognitive Function in Adults with or without Cognitive Impairment: A Systematic Review of Randomized Controlled Clinical Trials

Gutierrez, L., Folch, A., Rojas, M., Cantero, J. L., Atienza, M., Folch, J., Camins, A., Ruiz, A., Papandreou, C., & Bulló, M. (2021) · Nutrients

Nutritional Studies and DietDementia and Cognitive Impairment Research

Cited by 105

Masitinib for the treatment of mild to moderate Alzheimer’s disease

Folch, J., Petrov, D., Ettcheto, M., Pedrós, I., Abad, S., Beas-Zarate, C., Lazarowski, A., Marin, M., Olloquequi, J., Auladell, C., et al. (2015) · Expert Review of Neurotherapeutics

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 80

Long-term physical exercise induces changes in sirtuin 1 pathway and oxidative parameters in adult rat tissues

Bayod, S., del Valle, J., Lalanza, J. F., Sanchez-Roige, S., de Luxán-Delgado, B., Coto-Montes, A., Canudas, A. M., Camins, A., Escorihuela, R. M., & Pallàs, M. (2012) · Experimental Gerontology

Sirtuins and Resveratrol in MedicineExercise and Physiological Responses

Cited by 77

Lipid nanoparticles for the posterior eye segment

Bonilla, L., Espina, M., Severino, P., Cano, A., Ettcheto, M., Camins, A., García, M. L., Souto, E. B., & Sánchez-López, E. (2021) · Pharmaceutics

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 76

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice

Ettcheto, M., Cano, A., Manzine, P. R., Busquets, O., Verdaguer, E., Castro-Torres, R. D., García, M. L., Beas-Zarate, C., Olloquequi, J., Auladell, C., et al. (2020) · Molecular Neurobiology

Alzheimer's disease research and treatmentsTea Polyphenols and Effects

Cited by 73

Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease

Del Amo, L., Cano, A., Ettcheto, M., Souto, E. B., Espina, M., Camins, A., García, M. L., & Sánchez-López, E. (2021) · Applied Sciences

Nanoparticle-Based Drug DeliveryBarrier Structure and Function Studies

Cited by 67

Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)

Porquet, D., Andrés-Benito, P., Griñán-Ferré, C., Camins, A., Ferrer, I., Canudas, A. M., Del Valle, J., & Pallàs, M. (2015) · AGE

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 53

The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin

Folch, J., Patraca, I., Martínez, N., Pedrós, I., Petrov, D., Ettcheto, M., Abad, S., Marin, M., Beas-Zarate, C., & Camins, A. (2015) · Life Sciences

Alzheimer's disease research and treatmentsRegulation of Appetite and Obesity

Cited by 48

Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis

Verdaguer, E., Brox, S., Petrov, D., Olloquequi, J., Romero, R., de Lemos, M. L., Camins, A., & Auladell, C. (2015) · Experimental Gerontology

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 38

Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation–induced apoptosis involves the Akt pathway and inhibition of cell cycle reentry

Yeste-Velasco, M., Folch, J., Casadesús, G., Smith, M. A., Pallàs, M., & Camins, A. (2009) · Neuroscience

Cell death mechanisms and regulationProtein Kinase Regulation and GTPase Signaling

Cited by 31

Masitinib for the Treatment of Alzheimer’s Disease

Ettcheto, M., Cano, A., Sanchez-López, E., Verdaguer, E., Folch, J., Auladell, C., & Camins, A. (2021) · Neurodegenerative Disease Management

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 28

A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer’s Disease

Ettcheto, M., Busquets, O., Espinosa-Jiménez, T., Verdaguer, E., Auladell, C., & Camins, A. (2020) · Current Pharmaceutical Design

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 13

Study of the pathways involved in apoptosis induced by PI3K inhibition in cerebellar granule neurons

Torre, A. V. D. L., Junyent, F., Folch, J., Pelegrí, C., Vilaplana, J., Auladell, C., Beas-Zarate, C., Pallàs, M., Camins, A., & Verdaguer, E. (2011) · Neurochemistry International

Cell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

Cited by 11